NHS Bury Primary Care Trust Goes Live with iSOFT Lorenzo RC 1.9

iSOFTiSOFT Group Limited (ASX: ISF) - Australia's largest listed health information technology company today announced the implementation of the latest version of its Lorenzo electronic patient record solution at NHS Bury Primary Care Trust (PCT) in Lancashire. NHS Bury went live on 3 November with iSOFT's Lorenzo Regional Care 1.9.

The trust, through Local Service Provider CSC, is using Lorenzo Regional Care 1.9 for referral and caseload management as well as inpatient and outpatient functionality, supporting almost 600 community-based clinical and administrative users working across two wards and 1,200 clinics. The trust has plans to introduce clinical functionality in the coming months by using assessment functionality for orthopaedics and dietetics.

Gary Cohen, iSOFT's Executive Chairman & CEO, said: "The company is committed to helping trusts meet the IT goals set forward by the Department of Health Informatics Directorate and will remain diligent in ensuring they successful manage migrations from existing systems to Lorenzo. Bury PCT demonstrates a significant step forward for Lorenzo's strategic role within the National Programme for IT. The implementation teams have shown tenacity and determination to deliver a successful go-live and we are looking forward to further go-lives with this Trust, and a number of others, in the near future."

Adrian Stevens, Managing Director of iSOFT's UK and Ireland business, says the company remains committed to actively working with partner CSC on the delivery of Lorenzo Regional Care under the North, Midlands and East Programme for IT. "The Bury trust go-live is a particularly important achievement, both for iSOFT as well the National Programme, because this latest version of Lorenzo takes the efficient provision of healthcare in England to a new level. We will be closely monitoring the deployment at Bury over the coming weeks to ensure the system works well as staff continue to use this on a daily basis. We look forward to working with CSC and the NHS as we progress with this and further successful deployments. Looking beyond the success at Bury, iSOFT continues to actively support both CSC and NHS Connecting for Health in achieving the goals of the NPfIT and core IT strategy by continuing to deliver Lorenzo to the contracted regions in England," he said.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group’s sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,600 specialists in 18 locations worldwide, including more than 2,300 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organisational structure.

www.isofthealth.com

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...